NCT05354973View on ClinicalTrials.gov

ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy

RecruitingOBSERVATIONAL

Enrollment

11

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Patient Reported Outcome MeasuresCAR T-Cell Therapy

Interventions

DEVICE

Consilium CareTM

This is an observational study using the Consilium CareTM smartphone ePRO application.

Trial Locations (1)

8032

RECRUITING

Klinik für Hämatologie und Onkologie, Zurich

Sponsors

Collaborators (1)

Palleos Healthcare GmbH

All Listed Sponsors

collaborator

Klinik Hirslanden, Zurich

OTHER

collaborator

Palleos Healthcare GmbH

INDUSTRY

lead

Stiftung Swiss Tumor Institute

OTHER

NCT05354973 - ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy | Biotech Hunter | Biotech Hunter